John Sfakianos

9PUBLICATIONS
90CO-AUTHORS
Other creative arts and writing not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 09, 2026
Reply by Authors.

|Apr 19, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.

|Mar 17, 2026
Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky

|Feb 26, 2026
A Tumor-Promoting Inflammatory SPP1+ Macrophage-IL6-CRP Axis Drives Immune Dysfunction in Bladder Cancer.

Michelle A Tran, Byuri Angela Cho, Sudeh Izadmehr

|Jan 23, 2025
Immunotherapy-based neoadjuvant treatment and complication rates after radical cystectomy.

Reuben Ben-David, Francesco Pellegrino, Reza Mehrazin

|Oct 16, 2024
Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomes.

Reuben Ben-David, Sarah Lidagoster, Jack Geduldig

Pageof 2

Frequent Collaborators

7 joint publications

Reza Mehrazin

5 joint publications

Peter Wiklund

4 joint publications

Reuben Ben-David

4 joint publications

Matthew D Galsky